These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 28290229)
1. IncobotulinumtoxinA Injection for Temporomandibular Joint Disorder. Patel AA; Lerner MZ; Blitzer A Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):328-333. PubMed ID: 28290229 [TBL] [Abstract][Full Text] [Related]
2. IncobotulinumtoxinA in refractory temporomandibular disorder due to disk dislocation: A prospective study. Ferreira EF; Camões-Barbosa A J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(5S1):101804. PubMed ID: 38412921 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of IncobotulinumtoxinA Injection on Myalgia and Arthralgia in Patients Undergoing Temporomandibular Joint Arthroscopy: A Randomized Controlled Trial. Ângelo DF; Sanz D; Maffia F; Cardoso HJ Toxins (Basel); 2023 Jun; 15(6):. PubMed ID: 37368677 [TBL] [Abstract][Full Text] [Related]
5. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. Kurtoglu C; Gur OH; Kurkcu M; Sertdemir Y; Guler-Uysal F; Uysal H J Oral Maxillofac Surg; 2008 Aug; 66(8):1644-51. PubMed ID: 18634953 [TBL] [Abstract][Full Text] [Related]
6. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study. Sidebottom AJ; Patel AA; Amin J Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559 [TBL] [Abstract][Full Text] [Related]
7. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache. Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M J Headache Pain; 2016; 17():29. PubMed ID: 27011213 [TBL] [Abstract][Full Text] [Related]
8. Assessing change in functional outcomes and quality of life in myogenic temporomandibular disorders undergoing botulinum toxin injection: A before and after comparison. Hosgor H; Coskunses FM; Altindis S J Stomatol Oral Maxillofac Surg; 2023 Sep; 124(4):101434. PubMed ID: 36914004 [TBL] [Abstract][Full Text] [Related]
9. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. von Lindern JJ; Niederhagen B; Bergé S; Appel T J Oral Maxillofac Surg; 2003 Jul; 61(7):774-8. PubMed ID: 12856249 [TBL] [Abstract][Full Text] [Related]
10. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain. Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577 [TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(®)) in cervical dystonia. Evidente VG; Fernandez HH; LeDoux MS; Brashear A; Grafe S; Hanschmann A; Comella CL J Neural Transm (Vienna); 2013 Dec; 120(12):1699-707. PubMed ID: 23779062 [TBL] [Abstract][Full Text] [Related]
13. Clinical Aspects of the Use of Botulinum Toxin Type A in the Treatment of Dysfunction of the Masticatory System. Bogucki ZA; Kownacka M Adv Clin Exp Med; 2016; 25(3):569-73. PubMed ID: 27629747 [TBL] [Abstract][Full Text] [Related]
14. IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. Evidente VG; Truong D; Jankovic J; Comella CL; Grafe S; Hanschmann A J Neurol Sci; 2014 Nov; 346(1-2):116-20. PubMed ID: 25186131 [TBL] [Abstract][Full Text] [Related]
15. The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study. Rezazadeh F; Esnaashari N; Azad A; Emad S BMC Oral Health; 2022 May; 22(1):217. PubMed ID: 35641993 [TBL] [Abstract][Full Text] [Related]
16. Effect of multiple injections of botulinum toxin into painful masticatory muscles on bone density in the temporomandibular complex. Raphael KG; Janal MN; Tadinada A; Santiago V; Sirois DA; Lurie AG J Oral Rehabil; 2020 Nov; 47(11):1319-1329. PubMed ID: 32885475 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial. Jankovic J; Comella C; Hanschmann A; Grafe S Mov Disord; 2011 Jul; 26(8):1521-8. PubMed ID: 21520284 [TBL] [Abstract][Full Text] [Related]
18. Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials. Li K; Tan K; Yacovelli A; Bi WG J Oral Rehabil; 2024 May; 51(5):886-897. PubMed ID: 38151884 [TBL] [Abstract][Full Text] [Related]
19. Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A. Freund BJ; Schwartz M Headache; 2002; 42(10):1033-7. PubMed ID: 12453036 [TBL] [Abstract][Full Text] [Related]
20. Effect of jaw-opening exercise on prevention of temporomandibular disorders pain associated with oral appliance therapy in obstructive sleep apnea patients: A randomized, double-blind, placebo-controlled trial. Ishiyama H; Inukai S; Nishiyama A; Hideshima M; Nakamura S; Tamaoka M; Miyazaki Y; Fueki K; Wakabayashi N J Prosthodont Res; 2017 Jul; 61(3):259-267. PubMed ID: 28063976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]